GenScript Corporation – Trademark Portfolio

Entity Type: 03

GenScript Corporation holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GENE-ON-DEMAND. The owner is based in Piscataway, NJ.

120 Centennial Avenue

Piscataway, NJ 08854

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GenScript Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does GenScript Corporation have?

GenScript Corporation has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 3 cancelled.

What trademark classes does GenScript Corporation file in?

GenScript Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are GenScript Corporation's most well-known trademarks?

GenScript Corporation's registered trademark portfolio includes well-known marks such as GENE-ON-DEMAND. These are among 1 currently registered trademark in the portfolio.

What is GenScript Corporation's trademark registration success rate?

GenScript Corporation has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.